Cargando…

High Expression of miR-196b Predicts Poor Prognosis in Patients with Ovarian Cancer

BACKGROUND/AIMS: To analyze the clinical significance of miR-196b expression in ovarian cancer and predict the function and possible mechanism of miR-196b. METHODS: Both Kaplan–Meier (K-M) and Cox proportional hazards regression model were used to analyze the prognostic factors of patients with ovar...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yang, Li, Jing, Liu, Zirong, Zhang, Yamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534859/
https://www.ncbi.nlm.nih.gov/pubmed/33061458
http://dx.doi.org/10.2147/OTT.S254942
_version_ 1783590377714876416
author Li, Yang
Li, Jing
Liu, Zirong
Zhang, Yamin
author_facet Li, Yang
Li, Jing
Liu, Zirong
Zhang, Yamin
author_sort Li, Yang
collection PubMed
description BACKGROUND/AIMS: To analyze the clinical significance of miR-196b expression in ovarian cancer and predict the function and possible mechanism of miR-196b. METHODS: Both Kaplan–Meier (K-M) and Cox proportional hazards regression model were used to analyze the prognostic factors of patients with ovarian cancer. MiR196-b was modulated in ovarian cancer cells, and the cell viability, cell cycle, and cell cycle-related gene expression were analyzed. The target genes of miR-196b were then predicted and checked the relationship between the target genes. RESULTS: MiR-196b was an independent risk factor, while high expression of miR-196b was associated with poor prognosis of ovarian cancer. MiR-196b overexpression increased cancer cell proliferation. Cdkn1b, as one of the targets of miR-196b, was related to cell viability and mitosis. CONCLUSION: High expression of miR-196b was significantly associated with poor prognosis of the patients with ovarian cancer. MiR-196b could increase the cell proliferation of ovarian cancer by modulating Cdkn1b expression.
format Online
Article
Text
id pubmed-7534859
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-75348592020-10-14 High Expression of miR-196b Predicts Poor Prognosis in Patients with Ovarian Cancer Li, Yang Li, Jing Liu, Zirong Zhang, Yamin Onco Targets Ther Original Research BACKGROUND/AIMS: To analyze the clinical significance of miR-196b expression in ovarian cancer and predict the function and possible mechanism of miR-196b. METHODS: Both Kaplan–Meier (K-M) and Cox proportional hazards regression model were used to analyze the prognostic factors of patients with ovarian cancer. MiR196-b was modulated in ovarian cancer cells, and the cell viability, cell cycle, and cell cycle-related gene expression were analyzed. The target genes of miR-196b were then predicted and checked the relationship between the target genes. RESULTS: MiR-196b was an independent risk factor, while high expression of miR-196b was associated with poor prognosis of ovarian cancer. MiR-196b overexpression increased cancer cell proliferation. Cdkn1b, as one of the targets of miR-196b, was related to cell viability and mitosis. CONCLUSION: High expression of miR-196b was significantly associated with poor prognosis of the patients with ovarian cancer. MiR-196b could increase the cell proliferation of ovarian cancer by modulating Cdkn1b expression. Dove 2020-10-01 /pmc/articles/PMC7534859/ /pubmed/33061458 http://dx.doi.org/10.2147/OTT.S254942 Text en © 2020 Li et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Li, Yang
Li, Jing
Liu, Zirong
Zhang, Yamin
High Expression of miR-196b Predicts Poor Prognosis in Patients with Ovarian Cancer
title High Expression of miR-196b Predicts Poor Prognosis in Patients with Ovarian Cancer
title_full High Expression of miR-196b Predicts Poor Prognosis in Patients with Ovarian Cancer
title_fullStr High Expression of miR-196b Predicts Poor Prognosis in Patients with Ovarian Cancer
title_full_unstemmed High Expression of miR-196b Predicts Poor Prognosis in Patients with Ovarian Cancer
title_short High Expression of miR-196b Predicts Poor Prognosis in Patients with Ovarian Cancer
title_sort high expression of mir-196b predicts poor prognosis in patients with ovarian cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534859/
https://www.ncbi.nlm.nih.gov/pubmed/33061458
http://dx.doi.org/10.2147/OTT.S254942
work_keys_str_mv AT liyang highexpressionofmir196bpredictspoorprognosisinpatientswithovariancancer
AT lijing highexpressionofmir196bpredictspoorprognosisinpatientswithovariancancer
AT liuzirong highexpressionofmir196bpredictspoorprognosisinpatientswithovariancancer
AT zhangyamin highexpressionofmir196bpredictspoorprognosisinpatientswithovariancancer